RIVASTIGMINE TARTRATE
- Product NDC
- 27241-090
- 11-digit product format
- 272410090
- Labeler code
- 27241
- Product ID
- 27241-090_68bc0bb6-5493-438c-b2e4-1faf98b0d09a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- RIVASTIGMINE TARTRATE
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Ajanta Pharma Limited
- Application
- ANDA207797
- Marketing category
- ANDA
- Marketing start
- 2017-09-28
- Marketing end
- 0000-00-00
- Substance
- RIVASTIGMINE TARTRATE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 27241-090-06 | RIVASTIGMINE TARTRATE | 60 in 1 BOTTLE | CAPSULE | 60 | | 7 |
| 27241-090-50 | RIVASTIGMINE TARTRATE | 500 in 1 BOTTLE | CAPSULE | 500 | | 7 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 27241-090 | RIVASTIGMINE TARTRATE CAPSULE [AJANTA PHARMA LIMITED] | 7 | Legacy NDC, 2 package rows | 20180419_3d257f22-b504-4707-9b29-5ce9032667ca.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 27241-090-06 | 27241009006 | 60 in 1 BOTTLE | Historical |
| 27241-090-50 | 27241009050 | 500 in 1 BOTTLE | Historical |